Ignyta, Inc. RXDX was a big mover last session, as its shares rose nearly 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the healthcare company, as the stock is now trading above the volatile price range of $6.40 to $7.52 in the last one-month timeframe.
In the last 30 days, the company witnessed one positive estimate revision while the Zacks Consensus Estimate moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday's move higher can last.
Ignyta currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Investors interested in the Med-Drugs industry may consider better-ranked stocks like Ariad Pharmaceuticals Inc. ARIA, Avanir Pharmaceuticals, Inc. AVNR and Aeolus Pharmaceuticals Inc. (AOLS). All the three stocks carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
IGNYTA INC RXDX: Get Free Report
ARIAD PHARMA ARIA: Free Stock Analysis Report
AVANIR PHARM AVNR: Free Stock Analysis Report
AEOLUS PHARMACT (AOLS): Get Free Report
To read this article on Zacks.com click here.
Zacks Investment Research
Market News and Data brought to you by Benzinga APIsIn the last 30 days, the company witnessed one positive estimate revision while the Zacks Consensus Estimate moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday's move higher can last.
Ignyta currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Investors interested in the Med-Drugs industry may consider better-ranked stocks like Ariad Pharmaceuticals Inc. ARIA, Avanir Pharmaceuticals, Inc. AVNR and Aeolus Pharmaceuticals Inc. (AOLS). All the three stocks carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
IGNYTA INC RXDX: Get Free Report
ARIAD PHARMA ARIA: Free Stock Analysis Report
AVANIR PHARM AVNR: Free Stock Analysis Report
AEOLUS PHARMACT (AOLS): Get Free Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
